FDA approve donanemab treatment for early Alzhiemer disease

Name: FDA approve donanemab treatment for early Alzhiemer disease
Start: 2025-02-02T12:30:00+03:00
End: 2025-02-02T13:30:00+03:00
Location: كلية الصيدلة

2 February 2025 حلقة نقاشية

كلية الصيدلة

Asia/Baghdad timezone

Overview
Timetable
Registration

Contact

[email protected]

Session

FDA approve donanemab treatment for early Alzhiemer disease

2 Feb 2025, 12:30

كلية الصيدلة

There are no materials yet.

Building timetable...

FDA approve donanemab treatment for early Alzhiemer disease

Contact

Presentation materials

Share this page

Direct link

Social networks

Calendaring